AstraZeneca to invest $50bn in US by 2030 amid Trump tariff threats | AstraZeneca
AstraZeneca has announced it will invest $50bn (£37bn) in the US by 2030, the latest in a string of pledges by pharmaceutical companies as the threat of Donald Trump’s tariffs…
Share